America’s biopharmaceutical research companies are currently developing 420 medicines for patients suffering from neurological disorders, including epilepsy, Alzheimer’s disease, multiple sclerosis and Parkinson’s disease.
Phil Hagerman, CEO and Chairman of Diplomat Pharmacy, Inc., joined attendees as a special guest speaker for a “Specialty Lunch and Learn,” at McKesson’s ideaShare 2015. “Specialty is the new pharmacy,” Hagerman said.
New exchange plan enrollees spent less on medications in the first quarter of 2015 compared with the same time a year ago, according to the third edition of the Express Scripts Exchange Pulse report released on Wednesday.
What is the CVS Health competitive edge? To answer that question, CVS Health president and CEO Larry Merlo took the stage Wednesday during the UBS Global Healthcare Conference, a three-day conference in New York City that brings together investors and more than 200 companies across a variety of healthcare sectors.
While building a 4,500-store retail pharmacy powerhouse in the United States, Walmart also has kept pace with the specialty pharmacy revolution and is positioning itself to play a stronger role in this most innovative, dynamic and complex area of pharmaceutical R&D and bioengineering.
A specialty pharmacy in New York City’s posh Upper East Side is catering to wealthy residents with a new menu of concierge services that range from $2,500 to $6,500 a month, according to a Crain’s article.